Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.410-0.025(-1.74%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
VerifyMe, Inc. (VRME) reported Q1 2026 diluted earnings of -$0.05 per share.
The post VerifyMe Releases Q1 2026 Financial Results first appeared on Alphastreet.
Jet.AI Inc. (JTAI) reported Q1 2026 basic and diluted loss of $6.68 per share, a wider loss than the -$4.08 estimate (63.7% wider).
The post Jet.AI Releases Q1 2026 Financial Results first appeared on Alphastreet.
Galectin Therapeutics Inc.
The post Galectin Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Datavault AI Inc.
The post Datavault AI Releases Q1 2026 Financial Results first appeared on Alphastreet.
Wall Street expects Urban Outfitters, Inc. (NASDAQ:URBN) to report fiscal first-quarter 2027 earnings per share of $1.12 when the apparel retailer announces ...
The post Urban Outfitters Q1 2027 Earnings Preview — May 20, Street Expects $1.12 EPS first appeared on Alphastreet.
Wall Street Consensus. Analysts expect Intuit Inc. (NASDAQ:INTU) to report earnings per share of $12.57 when the financial software provider delivers its Q3...
The post Intuit Q3 2026 Earnings Preview May 20, Street Expects $12.57 EPS first appeared on Alphastreet.
BioCardia, Inc.
The post BioCardia Releases Q1 2026 Financial Results first appeared on Alphastreet.
PAVmed Inc. (PAVM) reported Q1 2026 non-GAAP adjusted loss of $1.17 per share, a wider loss than the -$0.69 estimate (69.6% wider), based on estimates f...
The post PAVmed Releases Q1 2026 Financial Results first appeared on Alphastreet.
Enveric Biosciences, Inc. (ENVB) posted Q1 2026 basic and diluted loss per share EPS of -$1.08.
The post Enveric Biosciences Releases Q1 2026 Financial Results first appeared on Alphastreet.
Cocrystal Pharma, Inc.
The post Cocrystal Pharma Releases Q1 2026 Financial Results first appeared on Alphastreet.
Annovis Bio, Inc.
The post Annovis Bio Releases Q1 2026 Financial Results first appeared on Alphastreet.
Traws Pharma, Inc.
The post Traws Pharma Releases Q1 2026 Financial Results first appeared on Alphastreet.
Sensei Biotherapeutics, Inc.
The post Sensei Biotherapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Indaptus Therapeutics, Inc.
The post Indaptus Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Instil Bio, Inc.
The post Instil Bio Releases Q1 2026 Financial Results first appeared on Alphastreet.
BioXcel Therapeutics, Inc. (BTAI) posted Full Year 2026 basic and diluted EPS of -$0.54.
The post BioXcel Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Substantial Beat. Legacy Education Inc. (AMEX:LGCY) delivered a strong Q3 2026 performance, posting adjusted earnings of $0.31 per share that crushed the St...
The post Legacy Education Delivers 22% Q3 2026 Upside, Revenue Up 15% first appeared on Alphastreet.
ARS Pharmaceuticals, Inc.
The post ARS Pharmaceuticals Releases Q1 2026 Financial Results first appeared on Alphastreet.
Legacy Education Inc. delivered a decisive Q3 2026 earnings beat, surpassing analyst estimates by 72.2% with adjusted EPS of $0.31 versus consensus of $0.18....
The post Legacy Education Q3 2026: $0.31 EPS Tops Estimates — Deep Dive first appeared on Alphastreet.
Earnings Beat Delivered. KinderCare Learning Companies, Inc. (NYSE:KLC) reported Q1 2026 adjusted earnings of $0.04 per share, substantially exceeding the -...
The post KinderCare Learning Companies Q1 2026 EPS Tops Expectations by 500.0% first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 21 210 770 |
| Enterprise Value: | 20 823 770 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| Telefon: | +48 (61) 851 86 77 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus

